Sinofn Health
Sinofn Health
The global pharmaceutical and nutraceutical landscape is undergoing a paradigm shift. We are moving away from "one-size-fits-all" supplementation toward Precision Nutrition. At SINOFN, our R&D roadmap focuses on bio-availability enhancement, utilizing advanced delivery systems like liposomal encapsulation and controlled-release micro-pellets. Consumer demands are shifting toward clean-label, plant-based, and clinically validated functional foods, particularly in the FSMP (Foods for Special Medical Purposes) category.
Modern procurement is no longer just about cost; it is about Supply Chain Resilience. International brands require agile partners who can manage raw material sourcing, regulatory compliance, and rapid prototyping. By integrating our R&D center in Tianjin with Shanghai's trading hub, we provide a dual-advantage: scientific depth and logistical velocity. Our "Profit with Purpose" model ensures that our manufacturing partners are not just suppliers, but stakeholders in a healthier global future.
Our commitment to the "Information Gain" principle means we constantly iterate on our formulation tech. Our future outlook involves the integration of AI in dietary formulation—matching metabolic profiles to nutrient ratios. Whether it is Phenylketonuria (PKU) management or sports nutrition optimization, our pipeline includes multi-stage fermentation, non-synthetic additive pathways, and sustainable sourcing protocols.
Founded in 2012, SINOFN was born from a clinical necessity. Witnessing the struggles of families with PKU, Mrs. Liu established our mission: to democratize access to life-sustaining medical nutrition. This medical-grade heritage defines our E-E-A-T profile—our manufacturing isn't just commercial; it is clinical.
A: SINOFN operates state-of-the-art facilities in China, adhering to strict ISO 22000, HACCP, and FSSC 22000 standards. Our "High-level geography" strategy ensures efficient export channels to global markets with full compliance certifications.
A: Absolutely. Our R&D center is designed for both scale and agility. We provide pilot-scale prototyping for tablets, capsules, and liquids, allowing brands to test market viability before full-scale production.
A: Our QA/QC department conducts rigorous testing, including HPLC and GC-MS contaminant screening, microbiological safety assessments, and long-term stability studies to ensure the efficacy of every batch.
